Canada's Drug Agency says new Alzheimer's drug should not be publicly funded | Page 20 | Unpublished
Hello!
Source Feed: Ottawa Citizen
Author: Elizabeth Payne
Publication Date: February 28, 2026 - 04:00

Stay informed

Canada's Drug Agency says new Alzheimer's drug should not be publicly funded

February 28, 2026
A decision by Canada’s Drug Agency will make it more difficult for Canadians to access a drug shown to slow Alzheimer’s disease in some people, says an Ottawa cognitive neurologist and researcher. Read More


Unpublished Newswire

 
Danielle Smith addressed the Rural Municipalities of Alberta conference, hearing concerns on everything from health care access to infrastructure woes and unpaid oil and gas taxes.
March 17, 2026 - 19:56 | Globalnews Digital | Global News - Canada
The Statistics Canada data, released March 10, shows Canadians are still travelling, just less frequently to the United States.
March 17, 2026 - 19:54 | Iris Dyck | Global News - Canada
The move brings the total cost associated with Calgary's Bearspaw feeder main to $439 million, which includes $381 million to pay for the replacement project.
March 17, 2026 - 19:44 | Adam MacVicar | Global News - Canada